Effects of a pragmatic home-based exercise program concurrent with neoadjuvant therapy on physical function of patients with pancreatic cancer. The PancFit randomized clinical trial.
Ngo-Huang AT, Parker NH, Xiao L, Schadler KL, Petzel MQB, Prakash L et al.
Ann Surg 2023; 278: 22-30.
Some 151 patients were included and all were given nutrition counselling and activity meters. Patients were randomized to additional aerobic and anaerobic resistance exercise during neoadjuvant chemotherapy. Six-minute walking distance was improved in both groups: 18.6 m in the usual care group and 27.3 m and those randomized to exercise. Clinical outcomes were similar.
Comment: No proof of any advantage for additional exercise.
12 October 2023Read paper
Part of the charitable activity of the Society, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.